Fungicidal fused bicyclic pyrimidinones

This invention relates to certain 4(3H)quinazolinones, their agriculturally suitable salts and compositions, and methods of their use as general or selective fungicides, in particular for the control of cereal powdery mildew both preventive and curative.

U.S. Pat. No. 3,755,582 and U.S. Pat. No. 3,867,384 disclose certain 4(3H)-quinazolinone fungicides. These patents, however, do not specifically disclose the compounds of the present invention.

SUMMARY OF THE INVENTION

This invention comprises compounds of Formulae I, II, and III including all geometric and stereoisomers, N-oxides, agriculturally-suitable salts thereof, agricultural compositions containing them and their use as fungicides:

wherein:

n is 0, 1 or 2;

Q is independently O or S;

R

1

is C

3

-C

10

alkyl; C

3

-C

5

cycloalkyl; C

4

-C

10

alkenyl; C

4

-C

10

alkynyl; C

1

-C

10

haloalkyl; C

3

-C

10

haloalkenyl; C

3

-C

10

haloalkynyl, C

2

-C

10

alkoxyalkyl; C

2

-C

10

alkylthioalkyl; C

2

-C

10

alkylsulfinylalkyl; C

2

-C

10

alkylsulfonylalkyl; C

5

-C

10

cycloalkylalkyl; C

4

-C

10

alkenyloxyalkyl; C

4

-C

10

alkynyloxyalkyl; C

4

-C

10

(cycloalkyl)oxyalkyl; C

4

-C

10

alkenylthioalkyl; C

4

-C

10

alkynylthioalkyl; C

6

-C

10

(cycloalkyl)thioalkyl; C

2

-C

10

haloalkoxyalkyl; C

4

-C

10

haloalkenyloxyalkyl; C

4

-C

10

haloalkynyloxyalkyl; C

4

-C

10

alkoxyalkenyl; C

4

-C

10

alkoxyalkynyl; C

4

-C

10

alkylthioalkenyl; C

4

-C

10

alkylthioalkynyl; C

4

-C

10

trialkylsilylalkyl; C

1

-C

10

alkyl substituted with NR

11

R

12

, nitro, cyano, or phenyl optionally substituted with R

14

, R

15

, and R

16

; C

1

-C

10

alkoxy; C

1

-C

10

haloalkoxy; C

1

-C

10

alkylthio; C

1

-C

10

haloalkylthio; NR

11

R

12

; or pyridyl, furanyl, thienyl, naphthyl, benzofuranyl, benzothienyl, or quinolinyl each optionally substituted with R

14

, R

15

, and R

16

;

R

2

is C

3

-C

10

alkyl, C

6

-C

7

cycloalkyl; C

3

-C

10

alkenyl; C

3

-C

10

alkynyl; C

1

-C

10

haloalkyl;, C

3

-C

10

haloalkenyl; C

3

-C

10

haloalkynyl; C

2

-C

10

alkoxyalkyl; C

2

-C

10

alkylthioalkyl; C

2

-C

10

alkylsulfinylalkyl; C

2

-C

10

alkylsulfonylalkyl; C

4

-C

10

cycloalkylalkyl; C

4

-C

10

alkenyloxyalkyl; C

4

-C

10

alkynyloxyalkyl; C

4

-C

10

(cycloalkyl)oxyalkyl; C

4

-C

10

alkenylthioalkyl; C

4

-C

10

alkynylthioalkyl; C

6

-C

10

(cycloalkyl)thioalkyl; C

2

-C

10

haloalkoxyalkyl; C

4

-C

10

haloalkenyloxyalkyl; C

4

-C

10

haloalkynyloxyalkyl; C

4

-C

10

alkoxyalkenyl; C

4

-C

10

alkoxyalkynyl; C

4

-C

10

alkylthioalkenyl; C

4

-C

10

alkylthioalkynyl; C

4

-C

10

trialkylsilylalkyl; C

3

-C

10

cyanoalkyl; C

2

-C

10

nitroalkyl; C

1

-C

10

alkyl substituted with CO

2

R

11

, NR

11

R

12

, or phenyl optionally substituted with R

13

, R

15

, and R

16

; phenyl optionally substituted with R

13

, R

15

, and R

16

; —N=CR

11

R

11

; or —NR

11

R

12

; or

R

1

and R

2

are taken together to form —CH

2

(CH

2

)

m

CH

2

—;

m is 1-4;

R

3

is halogen; C

1

-C

8

alkyl; C

3

-C

8

cycloalkyl; C

2

-C

8

alkenyl; C

2

-C

8

alkynyl; C

1

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

haloalkynyl; C

1

-C

8

alkoxy; C

1

-C

8

haloalkoxy; C

3

-C

8

alkenyloxy; C

3

-C

8

alkynyloxy; C

1

-C

8

alkylthio; C

3

-C

8

alkenylthio; C

3

-C

8

alkynylthio; C

1

-C

8

alkylsulfinyl; C

1

-C

8

alkysulfonyl; C

2

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

2

-C

8

alkylsulfinylalkyl; C

2

-C

8

alkylsulfonylalkyl; C

4

-C

8

cycloalkylalkyl; C

3

-C

8

trialkylsilyl; nitro; NR

11

R

12

; C

5

-C

8

trialkylsilylalkynyl; or phenyl optionally substituted with at least one R

13

.

R

4

is hydrogen; halogen; C

1

-C

4

alkyl; C

1

-C

4

haloalkyl; C

1

-C

4

alkoxy; or C

1

-C

4

haloalkoxy;

R

5

is C

3

-C

5

alkyl; C

7

-C

10

alkyl; C

4

-C

7

alkenyl; C

3

-C

5

alkynyl; C

1

-C

10

haloalkyl; C

5

-C

10

haloalkenyl; C

3

-C

10

haloalkynyl; C

2

-C

10

alkoxyalkyl other than methoxypropyl; C

2

-C

10

alkylthioalkyl; C

2

-C

10

alkylsulfinylalkyl; C

2

-C

10

alkylsulfonylalkyl; C

4

-C

10

cycloalkylalkyl; C

4

-C

10

alkenyloxyalkyl; C

4

-C

10

alkynyloxyalkyl; C

4

-C

10

(cycloalkyl)oxyalkyl; C

4

-C

10

alkenylthioalkyl; C

4

-C

10

alkynylthioalkyl; C

6

-C

10

(cycloalkyl)thioalkyl; C

2

-C

10

haloalkoxyalkyl; C

4

-C

10

haloalkenyloxyalkyl; C

4

-C

10

haloalkynyloxyalkyl; C

4

-C

10

alkoxyalkenyl; C

4

-C

10

alkoxyalkynyl; C

4

-C

10

alkylthioalkenyl; C

4

-C

10

alkylthioalkynyl; C

4

-C

10

trialkylsilylalkyl; C

1

-C

10

alkyl substituted with NR

11

R

12

, nitro, or phenyl optionally substituted with at least one of R

14

, R

15

, and R

16

; C

2

-C

10

alkyl substituted with cyano; C

1

-C

10

alkoxy; C

1

-C

10

haloalkoxy; C

1

-C

10

alkylthio; C

1

-C

10

haloalkylthio; NR

11

R

12

; or phenyl, furanyl, thienyl, naphthyl, benzofuranyl, or benzothienyl each optionally substituted with R

14

, R

15

, and R

16

;

R

6

is C

3

-C

10

alkyl: C

3

-C

7

alkenyl; C

3

-C

10

alkynyl, C

1

-C

10

haloalkyl; C

3

-C

10

haloalkenyl; C

3

-C

10

haloalkynyl; C

3

-C

10

alkoxyalkyl other than propoxymethyl; C

2

-C

10

alkylthioalkyl; C

2

-C

10

alkylsulfinylalkyl; C

2

-C

10

alkylsulfonylalkyl; C

4

-C

10

cycloalkylalkyl; C

4

-C

10

alkenyloxyalkyl; C

4

-C

10

alkynyloxyalkyl; C

4

-C

10

(cycloalkyl)oxyalkyl; C

4

-C

10

alkenylthioalkyl; C

4

-C

10

alkynylthioalkyl; C

6

-C

10

(cycloalkyl)thioalkyl; C

2

-C

10

haloalkoxyalkyl; C

4

-C

10

haloalkenyloxyalkyl; C

4

-C

10

haloalkynyloxyalkyl; C

4

-C

10

alkoxyalkenyl; C

4

-C

10

alkoxyalkynyl; C

4

-C

10

alkylthioalkenyl; C

4

-C

10

alkylthioalkynyl; C

4

-C

10

trialkylsilylalkyl; C

5

-C

10

cyanoalkyl; C

2

-C

10

nitroalkyl; or C

3

-C

10

alkyl substituted with CO

2

R

11

, NR

11

R

12

, or phenyl optionally substituted with R

13

, R

15

, and R

16

; or phenyl optionally substituted with R

13

, R

15

, and R

16

; or

R

5

and R

6

are taken together to form —CH

2

(CH

2

)

m

CH

2

—;

R

7

is C

3

-C

10

alkyl; C

3

-C

7

cycloalkyl; C

4

-C

7

alkenyl; propynyl; C

5

-C

10

alknyl; C

2

-C

10

haloalkyl; C

3

-C

10

haloalkenyl; C

3

-C

10

haloalkynyl; C

2

-C

10

alkoxyalkyl; C

2

-C

10

alkylthioalkyl; C

2

-C

10

alkylsulfinylalkyl; C

2

-C

10

alkylsulfonylalkyl; C

4

-C

10

alkenyloxyalkyl; C

4

-C

10

alkynyloxyalkyl; C

4

-C

10

(cycloalkyl)oxyalkyl; C

4

-C

10

alkenylthioalkyl; C

4

-C

10

alkynylthioalkyl; C

6

-C

10

(cycloalkyl)thioalkyl; C

2

-C

10

haloalkoxyalkyl; C

4

-C

10

haloalkenyloxyalkyl; C

4

-C

10

haloalkynyloxyalkyl; C

4

-C

10

alkoxyalkenyl; C

4

-C

10

alkoxyalkynyl; C

4

-C

10

alkylthioalkenyl; C

4

-C

10

alkylthioalkynyl; C

4

-C

10

trialkylsilylalkyl; C

1

-C

10

alkyl substituted with NR

11

R

12

or nitro; C

2

-C

10

alkyl substituted with cyano; C

1

-C

10

alkoxy; C

1

-C

10

haloalkoxy; C

1

-C

10

alkylthio; C

1

-C

10

haloalkylthio; NR

12

R

17

; or phenyl, pyridyl, furanyl, thienyl, naphthyl, benzofuranyl, benzothienyl, or quinolinyl each optionally substituted with R

14

, R

15

, and R

16

;

R

8

is hydrogen; C

1

-C

4

alkyl; or —C(=O)R

10

;

R

9

is hydrogen; C

2

-C

10

alkyl; C

3

-C

7

cycloalkyl; C

3

-C

10

alkenyl; C

3

-C

10

alkynyl; C

3

-C

10

haloalkyl; C

3

-C

10

haloalkenyl; C

3

-C

10

haloalknyl; C

3

-C

10

alkoxyalkyl other than butoxyethyl; C

2

-C

10

alkylthioalkyl; C

2

-C

10

alkylsulfinylalkyl; C

2

-C

10

alkylsulfonylalkyl; C

4

-C

10

cycloalkylalkyl; C

4

-C

10

alkenyloxyalkyl; C

4

-C

10

alkynyloxyalkyl; C

4

-C

10

(cycloalkyl)oxyalkyl; C

4

-C

10

alkenylthioalkyl; C

4

-C

10

alkynylthioalkyl; C

6

-C

10

(cycloalkyl)thioalkyl; C

2

-C

10

haloalkoxyalkyl; C

4

-C

10

haloalkenyloxyalyl; C

4

-C

10

haloalkynyloxyalkyl; C

4

-C

10

alkoxyalkenyl; C

4

-C

10

alkoxyalkynyl; C

4

-C

10

alkylthioalkenyl; C

4

-C

10

alkylthioalkynyl; C

4

-C

10

trialkylsilylalkyl; C

1

-C

10

alkyl substituted with NR

11

R

12

; C

4

-C

10

cyanoalkyl; C

2

-C

10

nitroalkyl; C

1

-C

8

alkyl substituted with CO

2

R

11

; pyridyl, furanyl, thienyl, or naphthyl each optionally substituted with R

14

, R

15

, and R

16

; —N=CR

11

R

11

; —NR

12

R

17

; —OR

12

; or —NC(=Q)NR

11

R

12

; or R

3

and R

4

are both iodine and R

9

is phenyl optionally substituted with R

14

, R

15

, and R

16

; or

R

7

and R

9

are taken together to form —CH

2

(CH

2

)

m

CH

2

—;

R

10

is hydrogen; C

1

-C

4

alkyl; C

1

-C

4

alkoxy; or NR

11

R

12

;

R

11

is independently hydrogen; C

1

-C

4

alkyl; or phenyl optionally substituted with at least one R

13

;

R

12

is independently hydrogen; C

1

-C

8

alkyl; or phenyl optionally substituted with at least one R

13

; or

R

11

and R

12

are taken together to form —CH

2

CH

2

CH

2

CH

2

—, —CH

2

(CH

2

)

3

CH

2

—, —CH

2

CH

2

OCH

2

CH

2

—, —CH

2

CH(Me)CH

2

CH(Me)CH

2

—, or —CH

2

CH(Me)OCH(Me)CH

2

—;

R

13

is independently halogen; C

1

-C

4

alkyl; C

1

-C

4

alkoxy; C

1

-C

4

haloalkyl; nitro; or cyano;

R

14

is independently C

1

-C

6

alkyl; C

1

-C

6

alkoxy; C

1

-C

6

haloalkyl; halogen; C

2

-C

8

alkynyl; C

1

-C

6

thioalkyl; phenyl or phenoxy each optionally substituted with at least one R

13

; cyano; nitro; C

1

-C

6

haloalkoxy; C

1

-C

6

haloalkylithio; C

2

-C

6

alkenyl; C

2

-C

6

haloalkenyl; acetyl; CO

2

Me; or N(C

1

-C

2

alkyl)

2

;

R

15

is independently methyl; ethyl; methoxy; methylthio; halogen; or trifluoromethyl;

R

16

is independently halogen; and

R

17

is independently C

1

-C

8

alkyl; or phenyl optionally substituted with at least one R

13

.

DETAILED DESCRIPTION OF THE INVENTION

In the above recitations, the term “alkyl”, used either alone or in compound words such as “alkythio,” “haloalkyl,” or “alkylthioalkyl” denotes straight-chain or branched alkyl; e.g.. methyl, ethyl, n-propyl, i-propyl, or the different butyl, pentyl, hexyl, etc. isomers.

“Cycloalkyl” denotes cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term “cycloalkyloxyalkyl” denotes the cycloalkyl groups linked through an oxygen atom to an alkyl chain. Examples include cyclopentyloxymethyl and cyclohexyloxybutyl. The term “cycloalkylthioalkyl” are the cycloalkyl groups linked through a sulfur atom to an alkyl chain; e.g., cyclopropylthiopentyl. “Cycloalkylalkyl” denotes a cycloalkyl ring attached to a branched or straight-chain alkyl; e.g. cyclopropylmethyl and cyclohexylbutyl.

“Alkenyl” denotes straight chain or branched alkenes; e.g., 1-propenyl, 2-propenyl, 3-propenyl and the different butenyl, pentenyl, hexenyl, etc. isomers. Alkenyl also denotes polyenes such as 1,3-hexadiene and 2,4,6- heptatriene.

“Alkynyl” denotes straight chain or branched alkynes; e.g., ethynyl, 1-propynyl, 3-propynyl and the different butynyl, pentynyl, hexynyl, etc. isomers. “Alkynyl” can also denote moieties comprised of multiple triple bonds; e.g., 2,7-octadiyne and 2,5,8-decatriyne.

“Alkoxy” denotes methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy, hexyloxy, etc. isomers. “Alkoxyalkenyl” and “alkoxyalkynyl” denoted groups in which the alkoxy group is bonded throught the oxygen atom to an alkenyl or alkynyl group, respectively. Examples include CH

3

OCH

2

CH=CH and (CH

3

)

2

CHOCH

2

C=CCH

2

. The corresponding sulfur derivatives are denoted “alkylthioalkenyl” and “alkylthioalkynyl.” Examples of the former include CH

3

SCH

2

CH═CH and CH

3

CH

2

SCH

2

(CH

3

)CH═CHCH

2

, and an example of the latter is CH

3

CH

2

CH

2

CH

2

SCH

2

C═C.

“Alkenyloxy” denotes straight chain or branched alkenyloxy moieties. Examples of alkenyloxy include H

2

C=CHCH

2

O, (CH

3

)

2

C=CHCH

2

O, (CH

3

)CH=CHCH

2

O, (CH

3

)CH=C(CH

3

)CH

2

O and CH

2

=CHCH

2

CH

2

O. “Alkenylthio” denotes the similar groups wherein the oxygen atom is replaced with a sulfur atom; e.g., H

2

C=CHCH

2

S and (CH

3

)CH=C(CH

3

)CH

2

S. The term “alkenyloxyalkyl” denotes groups in which the alkenyloxy moiety is attached to an alkyl group. Examples include H

2

C=CHCH

2

OCH

2

CH

2

, H

2

C=CHCH

2

OCH(CH

3

)CH

2

, etc. “Alkenylthioalkyl” denotes the alkenylthio moieties bonded to an alkyl group. Examples include H

2

C=CHCH

2

SCH(CH

3

)CH(CH

3

) and (CH

3

)CH=C(CH

3

)CH

2

SCH

2

.

“Alkynyloxy” denotes straight or branched alkynyloxy moieties. Examples include HC≡CCH

2

O, CH

3

C≡CCH

2

O and CH

3

C≡CCH

2

CH

2

O. “Alkynyloxyalkyl” denotes alkynyloxy moieties bonded to alkyl groups; e.g., CH

3

C≡CCH

2

OCH

2

CH

2

and HC≡CCH

2

OCH(CH

3

)CH

2

. “Alkynylthioalkyl” denotes alkynylthio moieties bonded to alkyl groups. Example include CH

3

≡CCH

2

SCH

2

CH

2

and CH

3

C≡CCH

2

CH

2

SCH(CH

3

)CH

2

.

“Alkylthio” denotes methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. “Alkylthioalkyl” denotes alkylthio groups attached to an alkyl chain; e.g., CH

3

CH

2

SCH

2

CH(CH

3

) and (CH

3

)

2

CHSCH

2

.

“Alkylsulfinyl” denotes both enantiomers of an alkylsulfinyl group. For example, CH

3

S(O), CH

3

CH

2

S(O), CH

3

CH

2

CH

2

S(O), (CH

3

)

2

CHS(O) and the different butylsulfinyl, pentylsulfinyl and hexylsufinyl isomers. “Alkylsulfinylalkyl” denotes alkylsulfinyl groups attached to an alkyl chain; e.g., CH

3

CH

2

S(O)CH

2

CH(CH

3

) and (CH

3

)

2

CHS(O)CH

2

.

Examples of “alkylsulfonyl” include CH

3

S(O)

2

, CH

3

CH

2

S(O)

2

, CH

3

CH

2

CH

2

S(O)

2

. (CH

3

)

2

CHS(O)

2

and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers. “Alkylsulfonylalkyl” denotes alkylsulfinyl groups attached to an alkyl chain: e.g. CH

3

CH

2

S(O)

2

CH

2

CH(CH

3

) and (CH

3

)

2

CHS(O)

2

CH

2

.

The term “halogen” either alone or in compound words such as “haloalkyl”, denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” include F

3

C, ClCH

2

, CF

3

CH

2

and CF

3

CF

2

. Examples of “haloalkenyl” include (Cl)

2

C=CHCH

2

and CF

3

CH

2

CH=CHCH

2

. “Haloalkenyloxyalkyl” denotes haloalkenyl groups bonded to oxygen and in turn bonded to alkyl groups. Examples include CF

3

CH

2

CH=CHCH

2

OCH

2

and (Cl)

2

C=CHCH

2

OCH

2

CH

2

. Examples of “haloalkynyl” include HC≡CCHCl, CF

3

C≡C, CCl

3

C≡C and FCH

2

C≡CCH

2

. “Haloalkynyloxyalkyl” denotes haloalkynyl groups bonded through an oxygen atom to an alkyl moiety. Examples include CF

3

C≡CCH

2

OCH

2

CH

2

, ClCH

2

C≡CCH

2

CH

2

OCH(CH

3

), etc. Examples of “haloalkoxy” include CF

3

O, CCl

3

CH

2

O, CF

2

HCH

2

CH

2

O and CF

3

CH

2

O. “Haloalkoxyalkyl” denotes haloalkoxy groups bonded to straight-chain or branched alkyl groups; e.g., CF

2

HCH

2

CH

2

OCH

2

CH

2

, CCl

3

CH

2

OCH(CH

3

) and CF

3

OCH

2

.

“Trialkylsilyl” designates a group with three alkyl groups bonded to silicon; e.g., (CH

3

)

3

Si and t-Bu(CH

3

)

2

Si. “Trialkylsilylalkyl” denotes trialkylsilyl growups bonded to another straight-chain or branched alkyl group. Examples include (CH

3

)

3

SiCH

2

and t-Bu(CH

3

)

2

SiCH

2

CH(CH

3

)CH

2

.

The total number of carbon atoms in a substituent group is indicated by the “C

i

-C

j

” prefix where i and j are numbers from 1 to 10. For example, C

1

-C

3

alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C

2

alkoxyalkoxy designates CH

3

OCH

2

O; C

3

alkoxyalkoxy designates, for example, CH

3

OCH

2

CH

2

O or CH

3

CH

2

OCH

2

O; and C

4

alkoxyalkoxy designates the various isomers of an alkoxy group substituted with a second alkoxy group containing a total of 4 carbon atoms, examples including CH

3

CH

2

CH

2

OCH

2

O, and CH

3

CH

2

OCH

2

CH

2

O. Examples of “alkoxyalkyl” include CH

3

OCH

2

, CH

3

OCH

2

CH

2

, CH

3

CH

2

OCH

2

, CH

3

CH

2

CH

2

CH

2

OCH

2

and CH

3

CH

2

OCH

2

CH

2

.

Preferred for reasons of ease of synthesis or greater fungicidal activity are:

Preferred 1. The compounds of Formula I as defined above wherein:

Q is O;

R

1

is C

3

-C

8

alkyl; C

4

-C

8

alkenyl; C

4

-C

8

alkynyl; C

1

-C

8

haloalkyl; C

3

-C

8

haloalkenyl: C

2

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

5

-C

8

cycloalkylalkyl: C

2

-C

8

alkyl substituted with cyano; C

1

-C

8

alkoxy: C

1

-C

8

haloalkoxy; C

1

-C

8

alkylthio; or C

4

-C

8

alkenyloxyalkyl; or pyridyl, furanyl, or thienyl each optionally substituted with R

14

and R

15

;

R

2

is C

3

-C

8

alkyl; C

1

-C

8

alkenyl; C

3

-C

8

alkynyl; C

1

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylalkyl; C

3

-C

8

cyanoalkyl; C

4

-C

8

alkenyloxyalkyl; or phenyl optionally substituted with R

13

;

R

3

is halogen; C

1

-C

8

alkyl; C

2

-C

8

alkynyl; C

3

-C

8

cycloalkyl; C

1

-C

8

haloalkyl; C

1

-C

8

alkoxy; C

1

-C

8

haloalkoxy; C

1

-C

8

alkylthio; C

1

-C

8

alkylsulfonyl; C

2

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylalkyl; or C

5

-C

8

trialkylsilylalkyyl; and

R

14

is methyl; ethyl; methoxy; ethoxy; C

1

-C

2

haloalkyl; halogen; acetylenyl; propargyl; methylthio; ethylthio; cyano; nitro; C

1

-C

2

haloalkoxy; vinyl; allyl; acetyl; CO

2

Me; or N(C

1

-C

2

alkyl)

2

.

Preferred 2. The compounds of Formula II as defined above wherein:

Q is O;

n is 0;

R

3

is halogen; C

1

-C

8

alkyl; C

2

-C

8

alkynyl; C

3

-C

8

cycloalkyl; C

1

-C

8

haloalkyl; C

1

-C

8

alkoxy; C

1

-C

8

haloalkoxy; C

1

-C

8

alkylthio; C

1

-C

8

alkylsulfonyl; C

2

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylkyl; or C

5

-C

8

trialkylsilylalkynyl;

R

5

is C

3

-C

5

alkyl; C

4

-C

7

alkynyl; C

3

-C

5

alkynyl; C

1

-C

8

haloalkyl; C

5

-C

8

haloalkenyl; C

2

-C

8

alkoxyalkyl other than methoxypropyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylalkyl; C

2

-C

8

alkyl substituted with cyano; C

1

-C

8

alkoxy; C

1

-C

8

haloalkoxy; C

1

-C

8

alkylithio; or C

4

-C

8

alkenyloxyalkyl; or phenyl, furanyl, or thienyl each optionally substituted with R

14

and R

15

;

R

6

is C

3

-C

8

alkyl; C

3

-C

7

alkenyl; C

3

-C

8

alkynyl; C

1

-C

8

haloalkyl; C

3

-C

3

haloalkenyl; C

3

-C

8

alkoxyalkyl other than propoxymethyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylalkyl; C

5

-C

8

cyanoalkyl; C

4

-C

8

alkenyloxyalkyl; phenyl optionally substituted with R

13

; or C

3

-C

5

alkyl substituted with phenyl optionally substituted with R

13

and R

15

; and

R

14

is methyl; ethyl; methoxy; ethoxy; C

1

-C

2

haloalkyl; halogen; acetylenyl; propargyl; methylthio; ethylthio; cyano; nitro; C

1

-C

2

haloalkoxy; vinyl; allyl; acetyl; CO

2

Me; or N(C

1

-C

2

alkyl)

2

.

Preferred 3. The compounds of Formula m as defined above wherein:

Q is O;

R

3

is halogen; C

1

-C

8

alkyl; C

2

-C

8

alknyl; C

3

-C

8

cycloalkyl; C

1

-C

8

haloalkyl; C

1

-C

8

alkoxy; C

1

-C

8

haloalkoxy; C

1

-C

8

alkylthio; C

1

-C

8

alkylsulfonyl; C

2

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylalkyl; or C

5

-C

8

trialkylsilylalkynyl;

R

7

is C

3

-C

8

alkyl; C

4

-C

7

alkenyl; propynyl; C

2

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

2

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

2

-C

8

alkyl substituted with cyano; C

1

-C

8

alkoxy; C

1

-C

8

haloalkoxy; C

1

-C

8

alkylthio; or C

4

-C

8

alkenyloxyalkyl; or phenyl, pyridyl, furanyl, or thienyl each optionally substituted with R

14

and R

15

;

R

9

is C

3

-C

8

alkyl; C

3

-C

8

alkenyl; C

3

-C

8

alkynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; C

2

-C

8

alkylthioalkyl; C

4

-C

8

cycloalkylalkyl; C

4

-C

8

cyanoalkyl; C

4

-C

8

alkenyloxyalkyl; —NR

12

R

17

; or R

3

and R

4

are both iodine and R

9

is phenyl optionally substituted with R

14

and R

15

; and

R

14

is methyl; ethyl; methoxy; ethoxy; C

1

-C

2

haloalkyl; halogen; acetylenyl; propargyl; methylthio; ethylthio; cyano; nitro; C

1

-C

2

haloalkoxy; vinyl; allyl; acetyl; CO

2

Me; or N(C

1

-C

2

alkyl)

2

.

Preferred 4. The compounds of Preferreds 1, 2, and 3 wherein:

R

1

is C

3

-C

8

alkyl; C

4

-C

8

alkenyl; C

4

-C

8

alkynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; or thienyl optionally substituted with at least one of R

14

and R

15

;

R

2

is C

3

-C

8

alkyl; C

3

-C

8

alkenyl; C

3

-C

8

alknyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; or phenyl optionally substituted with R

13

;

R

3

is halogen; C

1

-C

4

alkyl; C

1

-C

4

haloalkyl; C

1

-C

4

alkoxy; C

1

-C

4

haloalkoxy; acetylenyl; or trimethylsilylacetylenyl;

R

5

is C

3

-C

5

alkyl; C

4

-C

7

alkenyl; C

3

-C

5

alkynyl; C

3

-C

8

haloalkyl; C

5

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; or phenyl or thienyl each optionally substituted with R

14

and R

15

;

R

6

is C

3

-C

8

alkyl; C

3

-C

7

alkenyl; C

3

-C

8

alkyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; or phenyl optionally substituted with R

13

;

R

7

is C

3

-C

8

alkyl; C

4

-C

7

alkenyl; propynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxy; C

3

-C

8

alkoxyalkyl; or phenyl or thienyl each optionally substituted with R

14

and R

15

;

R

9

is C

3

-C

8

alkyl; C

3

-C

8

alkenyl; C

3

-C

8

alkynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; C

3

-C

8

alkoxyalkyl; —NR

12

R

17

; or R

3

and R

4

are both iodine and R

9

is phenyl optionally substituted with R

14

and R

15

; and

R

14

is methyl; ethyl; methoxy; methylthio; halogen; trifluoromethyl; or N(C

1

-C

2

alkyl)

2

.

Preferred 5. The compounds of Preferred 4 wherein:

R

1

is C

3

-C

8

alkyl; C

4

-C

8

alkenyl; C

4

-C

8

alkynyl; C

3

-C

8

haloalkyl; or C

3

-C

8

haloalkenyl;

R

2

is C

3

-C

8

alkyl; C

3

-C

8

alkenyl; C

3

-C

8

alkynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; or phenyl optionally substituted with R

13

;

R

3

is halogen;

R

4

is hydrogen or halogen;

R

5

is C

3

-C

5

alkyl; C

4

-C

7

alkenyl; C

3

-C

5

alkynyl; C

3

-C

8

haloalkyl; or C

5

-C

8

haloalkenyl; or phenyl optionally substituted with R

14

and R

15

;

R

6

is C

3

-C

8

alkyl; C

3

-C

7

alkenyl; C

3

-C

8

alkynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; or phenyl optionally substituted with R

13

;

R

7

is C

3

-C

8

alkyl; C

4

-C

7

alkenyl; propynyl; C

3

-C

8

haloalkyl; or C

3

-C

8

haloalkenyl; or phenyl optionally substituted with R

14

and R

15

; and

R

9

is C

3

-C

8

alkyl; C

3

-C

8

alkenyl; C

3

-C

8

alkynyl; C

3

-C

8

haloalkyl; C

3

-C

8

haloalkenyl; —NR

12

R

17

; or R

3

and R

4

are both iodine and R

9

is phenyl optionally substituted with R

14

and R

15

.

Preferred 6. The compounds of Preferred 5 wherein said compounds are selected from the group:

6-bromo-3-propyl-2-propyloxy-4(3H)-quinazolinone;

6,8-diiodo-3-propyl-2-propyloxy-4(3H)-quinazoline;

6-iodo-3-propyl-2-propyloxy-4(3H)-quinazolinone; and

6,8-diiodo-3-propyl-2(phenylamino)-4(3H)-quinazolinone.

It is recognized that some reagents and reaction conditions described below for preparing compounds of Formulae I, II, and III may not be compatible with some functionalities claimed for R

1

-R

17

, n, m, and Q. In these cases, the incorporation of protection/deprotection sequences into the synthesis may be necessary in order to obtain the desired products. The cases in which protecting groups are necessary, and which protecting group to use, will be apparent to one skilled in chemical synthesis. See Greene, T. W. and Wuts, P. G. M.;

Protective Groups in Organic Synthesis,

2nd Ed.; John Wiley & Sons, Inc.; New York, (1980) for suitable protecting groups.

In the following description of the preparation of compounds of Formulae I, II, and III, compounds of Formulae Ia and Ib, IIa-IIc, and IIIa-IIIe are various subsets of the compounds of Formulae I, II, and III. All substituents in compounds of Formulae Ia and Ib, IIa-IIc, and IIIa-IIIe and 2-7 are as defined above for Formulae I, II, and III.

Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active than the others and how to separate said stereoisomers. Accordingly, the present invention comprises mixtures, individual stereoisomers, and optically active mixtures of compounds of Formulae I, II, and III as well as agriculturally suitable salts thereof.

The compounds of Formulae I, II, and III can be prepared as described below in Schemes 1-9 and Examples 1-3.

Synthesis of Compounds of Formula I

Compounds of Formula Ia, compounds of Formula I wherein Q is O, can be made by the method illustrated in Scheme 1.

An anthranilic acid (2-aminobenzoic acid) of Formula 2 is condensed with an isothiocyanate of Formula R

1

-NCS to form the 2-thioquinazolinedione of Formula 3. This condensation is preferably performed in the presence of a base such as triethylamine. S-Methylation of this compound affords the 2-methylthio-4(3H)-quinazolinone of Formula 4.

For the introduction of the R

2

O group, the 2-methylthio-4(3H)-quinazolinone of Formula 4 is treated with a mixture of a base, for example sodium hydride, in R

2

OH solvent. The reaction mixture is stirred at a temperature from about 0° C. to 120° C. for 1-120 hours. The desired 2-R

2

O-4(3H)-quinazolinone can be isolated from the reaction mixture by extraction into a water-immiscible solvent, and purified by chromatography or recrystallization. Similar synthetic procedures are described in U.S. Pat. No. 3,755,582, incorporated herein by reference.

Anthranilic acids of Formula 2 are known or can be prepared by known methods. For example see, March,

J. Advanced Organic Chemistry;

3rd ed., John Wiley: New York, (1985), p 983. The isothiocyanates of Formula R

1

-NCS can be prepared from the corresponding amine by treatment with thiophosgene as known in the art. For example, see

J. Heterocycl. Chem.,

(1990), 27,407.

Alternatively, 2-thioquinazolinediones of Formula 3 can be prepared by treatment of the (C

1

-C

4

alkyl) anthranilic acid ester of Formula 5 with thiophosgene to form the isothiocyanate ester, followed by treatment with an amine of formula R

1

NH

2

(Scheme 2).

The anthranilic acid ester of Formula 5 is treated with thiophosgene at a temperature from about −20° C. to 100° C. for 1 to 48 hours optionally in an inert solvent. Often this reaction is performed in a biphasic mixture in the presence of a base, such as calcium carbonate, and an acid, such as aqueous hydrochloric acid. The resulting isothiocyanate may be isolated by extraction into a water-immiscible solvent, such as methylene chloride, followed by drying of the organic extracts and evaporation under reduced pressure. Alternatively, the isothiocyanate can be combined in situ with the amine of Formula H

2

-NR

1

and stirred at about −20° C. to 50° C. for 0.1 to 24 hours. The desired 2-thioquinazolinediones of Formula 3 can be isolated from the reaction mixture by aqueous extraction, and purified by chromatography or recrystallization. Similar synthetic procedures are described in

J. Heterocycl. Chem., (

1990), 27,407.

Compounds of Formula Ib, compounds of Formula I wherein Q is S, can be prepared as illustrated in Scheme 3.

Treatment of the quinazolinone of Formula Ia with phosphorous pentasulfide or Lawesson's reagent [2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide] in an inert solvent such as dioxane at a temperature 0° C. to the reflux temperature of the solvent for 0.1 to 72 hours affords the quinazolinethione of Formula Ib. This procedure is described in the literature, for example see U.S. Pat. No. 3,755,582.

Syntheses of Compounds of Formula II

4(3H)-Quinazolinones of Formula IIa, compounds of Formula II wherein n is 0 and Q is O, can be prepared by a modification of the synthesis illustrated in Scheme 1. As illustrated in Scheme 4, the 2-thioquinazolinedione of Formula 6 is alkylated with R

6

-X wherein X is a typical leaving group such as Br, I, CH

3

SO

3

(OMs), or (4-CH

3

-Ph)SO

3

(OTs) to afford the 2-R

6

S-4(3H)-quinazolinone of Formula IIa. One or more equivalents of a base can be used to accelerate the process. Bases such as sodium hydroxide and sodium hydride are suitable.

Typically, the 2-thioquinazolinedione is dissolved or dispersed in an inert solvent such as dimethylformamide and treated with a base at a temperature from about −20° C. to 60° C. with a base. The reaction mixture may then be heated to just above ambient temperature to the reflux temperature of the solvent for 0.1 to 24 hours to effect deprotonation. After cooling, the reaction mixture is cooled and treated with R

6

-X and stirred for 0.1-24 hours at a temperature from about 20° C. to the reflux temperature of the solvent. The quinazolinone of Formula IIa can be isolated by extraction into a water-immiscble solvent, and purified by chromatography or recrystallization.

2-Thioquinazolinediones of Formula 6 are prepared as described above in Schemes 1 and 2 for 2-thioquinazolinediones of Formula 3.

4(3H)-Quinazolinones of Formula IIb, compounds of Formula II wherein Q is O and n is 1 or 2, can be prepared by oxidation of the corresponding —SR

6

compound of Formula Ia using well-known procedures for oxidation of sulfar (Scheme 5). For example, see March,

J. Advanced Organic Chemistry;

3rd ed., John Wiley: New York, (1985), p 1089.

4(3H)-Quinazolinethiones of Formula IIc, compounds of Formula II wherein Q is S, can be prepared by treatment of the corresponding quinazolinone with phosphorous pentasulfide or Lawesson's reagent as described in U.S. Pat. No. 3;755,582 and above for compounds of Formula Ib (Scheme 6).

Synthesis of Compounds of Formula III

4(3H)-Quinazolinones of Formula IIIa, compounds of Formula III wherein Q is O, can be prepared by the method illustrated in Scheme 7. This method is described in detail in U.S. Pat. No. 3,867,384 and incorporated herein by reference.

One method of preparation of compounds of Formula IIIa is by treatment of a 2-methylthio-4(3H)-quinazolinone of Formula 7 (Z=SMe) with an excess of an amine of Formula HNR

8

R

9

at about 150° C. to 175° C. A second method is to contact a 2-chloro-4(3H)-quinazolinone of Formula 7 (Z=Cl) with one equivalent of HNR

8

R

9

and one equivalent of an acid scavenger, for example triethylamine, or with two equivalents of HNR

8

R

9

, at a temperature between 60° C. and 120° C. optionally in the presence of a solvent.

The preparation of compounds of Formula 7 wherein Z is SMe is described above and in U.S. Pat. No. 3,755,582. The synthesis of compounds of Formula 7 wherein Z is Cl is described in U.S. Pat. No. 3,867,384. Amines of Formula HNR

8

R

9

are commercially available or can be prepared by well-known methods (March,

J. Advanced Organic Chemistry;

3rd ed., John Wiley: New York, (1985), p 1153).

In addition to the methods described above, compounds of Formula Ia and IIa can be prepared by displacement of the 2-chlorine in the appropriate 4(3H)-quinazolinone, rather than by displacement of the 2-SCH

3

group (Scheme 1) or S-alkylation of the thiocarbonyl (Scheme 4).

As described above for compounds of Formula Ib and IIc, quinazolinethiones of Formula IIIb can be prepared by treatment of the corresponding quinazolinone with P

2

S

5

or Lawesson's reagent (Scheme 8).

Alternatively, 4(3H)-quinazolinones and quinazolinethiones of Formulae IIId and IIIe, compounds of Formula III wherein R

8

=—C(=O)R

12

, can be prepared by acylation of the corresponding quinazolinones or quinazolinethione wherein R

8

=H (Formula IIIc) as illustrated in Scheme 9.

The quinazolinones of Formula IIIc can be treated with an acylating agent of Formula R

10

C(=O)L wherein L is an appropriate leaving group such as chlorine or OC(=O)(H or C

1

-C

4

alkyl). In a similar fashion, compounds of Formula III wherein R

8

is —C(=O)NHR

12

(Formula IIIe) can be prepared by condensing quinazolinones of Formula IIIc with isocyanates of Formula R

14

N=C=O using well known procedures.

Salts of compounds of Formulae I, II, and III can be formed by treating the free base of the corresponding compound with strong acids such as hydrochloric or sulfuric acid. Salts can also be prepared by alkylation of a tertiary amine group in the molecule to form, for example, the trialkylammonium salt. N-Oxides of compounds of Formulae I. II, and III can be made by oxidizing the corresponding reduced nitrogen compound with a strong oxidizing agent such as meta-chloroperoxybenzoic acid.

EXAMPLE 1

Synthesis of 6-Bromo-3-propyl-2-propyloxy-4(3H)-quinazolinone

All reactions were conducted under a nitrogen atmosphere.

Step A

To a solution of 200 mL of ethanol containing 37 g of 2-amino-5-bromobenzoic acid was added dropwise 17.72 mL of n-propyl isothiocyanate with stirring. The mixture was heated at reflux for 8 h, allowed to cool to room temperature and stirred for approximately 60 h. The mixture was then cooled to approximately 5° C. and filtered to obtain 15.42 g of an off-white solid.

Step B

To a solution containing 15.4 g of the product of Step A dissolved in 100 mL of 10% propanolic sodium hydroxide was added 3.2 mL of iodomethane with stirring. The mixture was stirred at room temperature for 10 min, then heated at reflux for 1.5 h, and then allowed to cool to room temperature and stirred overnight. The reaction mixture was filtered to obtain 11.47 g of a white solid. The white solid was purified by column chromatography on silica gel eluting with hexane and then 9:1 hexane:ethyl acetate. Collection and evaporation of those fractions containing the least polar component (according to thin layer chromatography, 6:1 hexane/ethyl acetate mixture as the development solvent) yielded 6.55 g of a white solid, m.p. 97-99° C.

Step C

To 150 mL of propanol cooled to approximately −60° C. was added 0.83 g of 1 aH (60% active in oil) with stirring. To this mixture at −60° C. was added 6.5 g of the purified product obtained in Step B. The mixture was allowed to warm to room temperature and stirred for approximately 48 h to yield a clear solution. The reaction solution was poured into water and extracted twice with diethyl ether. The ether extracts were washed twice with water, dried over magnesium sulfate, filtered and the filtrate was then evaporated to yield 10.3 g of an oil. Thin layer chromatography indicated starting material and desired product were both present.

Step D

To propanol cooled to −50° C. was added 0.60 g of NaH (60% active in oil) with stirring. To this mixture at −40° C. was added the product of Step C and the mixture was allowed to warm to room temperature and stirred for approximately 72 h. The mixture was then heated at reflux for 30 min. cooled to room temperature, poured into water and extracted twice with diethyl ether. The combined ether extracts were washed three times with water, dried over magnesium sulfate, filtered and the filtrate was evaporated to yield an oil. The oil was purified by column chromatography on silica gel eluting with hexane followed by 9:1 hexane/ethyl acetate. Collection and evaporation of the fractions containing only the least polar component (according to thin layer chromatography on silica gel, 9:1 hexane/ethyl acetate mixture as the development solvent) yielded 4.46 g of the title compound as a white solid, m.p. 57-59° C:

1

H NMR (400 MHz, CDCl

3

) δ 8.3 (s,1H), 7.7 (m,1H), 7.3 (m,1H), 4.43 (t,2H), 4.05 (t,2H), 1.85 (m,2H), 1.7 (m,2H), 1.06 (t,3H), 0.97 (t,3H).

EXAMPLE 2

Synthesis of 6-Bromo-3-n-butyl-2-n-propylamino-4(3H)-quinazolinone

Step A

To a solution of 200 mL of ethanol containing 15.15 g of 2-amino-5-bromobenzoic acid was added dropwise 9.3 mL of n-butyl isothiocyanate with stirring. To this reaction solution was added 9.77 mL of triethylamine. The reaction solution was heated at reflux for 4 h during which time a solid precipitated. The reaction mixture was cooled to 0° C. and filtered to obtain 19.89 g of an off-white solid, m.p. 246-248° C.

Step B

To a solution containing 7 g of the product of Step A suspended in 50 mL of chloroform was added 1.97 mL of sulfuryl chloride with stirring. The solution was heated at reflux for 5 h, then cooled to room temperature. The reaction solution was poured into water and extracted twice with methylene chloride. The organic extracts were dried over magnesium sulfate, filtered and the filtrate was then evaporated to a yellow solid. The solid was purified by column chromatography on silica gel eluting with 6:1 hexane/ethyl acetate. Collection and evaporation of the fractions containing only the second-least polar component (according to thin layer chromatography on silica gel, 4:1 hexane/ethyl acetate mixture as the development solvent) yielded 3.2 g of white solid. m.p. 56-58° C.

Step C

To a solution containing 1.02 g of the purified product obtained in Step B dissolved in 25 mL of tetrahydrofuran was added 0.5 mL of n-propylamine. The reaction mixture was stirred for approximately 24 h at room temperature. The reaction was then filtered and the filtrate was evaporated to obtain an oil. The oil was dissolved in diethyl ether and washed twice with water and once with brine. The ether solution was dried over magnesium sulfate, filtered and the filtrate was then evaporated to yield 0.74 g of the title compound as a white solid, m.p. 71-73° C:

1

H NMR (400 MHz, CDCl

3

) 0.97-1.04 (m,6H). 1.45 (m,2H). 1.70 (m,4H), 3.50 (m,2H), 4.00 (t,2H), 4.50 (s,1H), 7.24 (d,1H), 7.60 (d,1H), 8.20 (s,1H).

EXAMPLE 3

Synthesis of 6-Bromo-3-n-propyl-2-n-propylthio-4(3H)-quinazolinone

Step A

To a solution of 150 mL isopropanol containing 29.7 g of 2-amino-5-bromobenzoic acid was added dropwise. 15.64 mL of n-propyl isothiocyanate with stirring. The reaction mixture was then heated at reflux for 15 h. The reaction mixture was cooled to 0° C. and filtered to obtain 9.12 g of an off-white solid.

Step B

To a solution containing 0.34 g of the product of Step A suspended in 20 mL of 10% propanolic sodium hydroxide was added 0.22 mL of iodopropane with stirring. The reaction mixture was stirred 1.5 h at room temperature. The reaction was poured into water and extracted twice with methylene chloride. The methylene chloride extractions were washed twice with water, dried over magnesium sulfate, filtered, and the filtrate was then evaporated to yield a white solid. The solid was purified by column chromatography on silica gel eluting with 8:1 hexane/ethyl acetate. Collections and evaporation of the fractions containing only the least-polar component (according to thin layer chromatography on silica gel, 6:1 hexane/ethyl acetate mixture as the development solvent) yielded 0.27 g of the title compound as a white solid, m.p. 65-67° C.:

1

H NMR (400 MHz, CDCl

3

): δ0.99-1.10 (m,6H), 1.80 (m,4H), 3.25 (t,2H), 4.10 (t,2H), 7.41 (d,1H), 7.78 (d,1H), 8.30 (s,1H).

Using the procedures outlined in Schemes 1-9 and Examples 1-3, the compounds of Tables 1-12 hereinafter can be prepared. The compounds referred to in the Tables which follow are illustrated below:

The following abbreviations are used in the Tables which follow . All alkyl groups are the normal isomers unless indicated otherwise. See structures in Index Tables A-C hereinafter for ring system numbering.

t = tertiary

MeO = methoxy

s = secondary

Pr = propyl

n = normal

CN = cyano

i = iso

c = cyclo

Me = methyl

MeS = methylthio

Et = ethyl

Bu = butyl

Ph = phenyl

TABLE 1

R

1

R

1

R

1

R

1

Compounds of Formula I wherein: Q = O, R

2

= n-Pr, R

3

= 6-Br, R

4

= H, and

n-Pr

n-Bu

n-pentyl

n-hexyl

n-decyl

i-Pr

i-Bu

s-Bu

c-propyl

c-butyl

c-pentyl

2-butenyl

3-butenyl

2-butynyl

3-butynyl

CF

3

2-Cl-Et

3-Br-Pr

CH

2

CH═CHCl

CH

2

C≡CCl

CH

2

OCH

3

CH

2

OCH

2

CH

3

CH

2

SCH

3

CH

2

SCH

2

CH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

S(O)CH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

OCH

2

CH≡CH

(c-hexyl)OCH

2

(c-pentyl)SCH

2

CH

2

CH

2

SCH

2

CH═CH

2

CH

2

CH

2

SCH

2

CH≡CH

CH

2

OCF

3

CH

2

OCH

2

CH

2

Cl

CH

2

OCH

2

CH═CHCl

CH

2

OCH

2

C≡CBr

CH

2

CH═CHCH

2

OCH

3

CH

2

C≡CCH

2

OCH

3

CH

2

CH═CHCH

2

SCH

3

CH

2

C≡CCH

2

SCH

3

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

N(CH

3

)

2

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

CH

2

CH

2

CH

2

CN

PhCH

2

OCH

2

CH

2

CH

3

OCH

2

CH

2

CF

3

SCH

2

CH

3

SCCl

3

SCH

2

CH

2

Cl

NHCH

2

CH

2

CH

3

N(CH

3

)CH

2

CH

3

Ph

2-pyridinyl

2-furanyl

2-thienyl

2-naphthyl

5-benzofuranyl

3-benzothienyl

3-quinolinyl

(4-F-Ph)CH

2

Compounds of Formula I wherein: Q = O, R

2

= n-Pr, R

3 =

6-I, R

4

= H, and

n-Pr

n-Bu

n-pentyl

n-hexyl

n-decyl

i-Pr

i-Bu

s-Bu

c-propyl

c-butyl

c-pentyl

2-butenyl

3-butenyl

2-butynyl

3-butynyl

CF

3

2-Cl-Et

3-Br-Pr

CH

2

CH═CHCl

CH

2

C≡CCl

CH

2

OCH

3

CH

2

OCH

2

CH

3

CH

2

SCH

3

CH

2

SCH

2

CH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

S(O)CH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

OCH

2

C≡CH

(c-hexyl)OCH

2

(c-pentyl)SCH

2

CH

2

CH

2

SCH

2

CH═CH

2

CH

2

CH

2

SCH

2

C≡CH

CH

2

OCF

3

CH

2

OCH

2

CH

2

Cl

CH

2

OCH

2

CH═CHCl

CH

2

OCH

2

C≡CBr

CH

2

CH═CHCH

2

OCH

3

CH

2

C≡CCH

2

OCH

3

CH

2

CH═CHCH

2

SCH

3

CH

2

C≡CCH

2

SCH

3

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

N(CH

3

)

2

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

CH

2

CH

2

CH

2

CN

(4-F-Ph)CH

2

OCH

2

CH

2

CH

3

OCH

2

CH

2

CF

3

SCH

2

CH

3

SCCl

3

SCH

2

CH

2

Cl

NHCH

2

CH

2

CH

3

N(CH

3

)CH

2

CH

3

PhCH

2

2-pyridinyl

2-furanyl

2-thienyl

2-naphthyl

5-benzofuranyl

3-benzothienyl

3-quinolinyl

(2-Me-Ph)CH

2

CH

2

Compounds of Formula I wherein: Q = O, R

2

= n-Pr, R

3

= 6-I, R

4

= 8-1, and

n-Pr

n-Bu

n-pentyl

n-hexyl

n-decyl

i-Pr

i-Bu

s-Bu

c-propyl

c-butyl

c-pentyl

2-butenyl

3-butenyl

2-butynyl

3-butynyl

CF

3

2-Cl-Et

3-Br-Pr

CH

2

CH═CHCl

CH

2

C≡CCl

CH

2

OCH

3

CH

2

OCH

2

CH

3

CH

2

SCH

3

CH

2

SCH

2

CH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

S(O)CH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

OCH

2

C≡CH

(c-hexyl)OCH

2

(c-pentyl)SCH

2

CH

2

CH

2

SCH

2

CH═CH

2

CH

2

CH

2

SCH

2

C≡CH

CH

2

OCF

3

CH

2

OCH

2

CH

2

Cl

CH

2

OCH

2

CH═CHCl

CH

2

OCH

2

C≡CBr

CH

2

CH═CHCH

2

OCH

3

CH

2

C≡CCH

2

OCH

3

CH

2

CH═CHCH

2

SCH

3

CH

2

C≡CCH

2

SCH

3

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

N(CH

3

)

2

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

CH

2

CH

2

CH

2

CN

PhCH

2

OCH

2

CH

2

CH

3

OCH

2

CH

2

CF

3

SCH

2

CH

3

SCCl

3

SCH

2

CH

2

Cl

NHCH

2

CH

2

CH

3

N(CH

3

)CH

2

CH

3

(2-Me-Ph)CH

2

CH

2

2-pyridinyl

2-furanyl

2-thienyl

2-naphthyl

5-benzofuranyl

3-benzothienyl

3-quinolinyl

(4-F-Ph)CH

2

TABLE 2

R

2

R

2

R

2

R

2

Compounds of Formula I wherein: Q = O, R

1

= n-Pr, R

3

= 6-Br, R

4

= H, and

CH

2

CH

2

CH

2

F

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

c-hexyl

allyl

2-butenyl

3-butenyl

5-decenyl

propargyl

2-butynyl

3-butynyl

CF

3

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

CH

2

OCH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

CH

2

CH

2

CH

2

CN

CH

2

CH

2

Si(CH

3

)

3

—NHPh

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

CH

2

(4-F-Ph)

—N(CH

3

)Ph

CH

2

CH

2

CH

2

N(CH

3

)

2

CH

2

CH

2

CH

2

Ph

CH

2

CH

2

CH

2

F

CH

2

Ph

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

Ph

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—N═CHPh

CH

2

CH

2

(4-F-Ph)

—N═CHCH

2

CH

2

CH

3

—N═C(CH

3

)

2

NHCH

2

CH

2

CH

3

N(CH

3

)

2

Compounds of Formula 1 wherein: Q = O, R

1

= n-Pr, R

3

= 6-I, R

4

= H, and

CH

2

CH

2

CH

2

F

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

c-hexyl

allyl

2-butenyl

3-butenyl

5-decenyl

propargyl

2-butynyl

3-butynyl

CF

3

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

CH

2

OCH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

CH

2

CH

2

CH

2

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

Ph

4-Me-Ph

CH

2

CH

2

CH

2

N(CH

3

)

2

2-F-Ph

4-MeO-Ph

CH

2

Ph

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

Ph

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—N═CHPh

CH

2

CH

2

(4-F-Ph)

—N═CHCH

2

CH

2

CH

3

—N═C(CH

3

)

2

NHCH

2

CH

2

CH

3

N(CH

3

)

2

2,4-diCl-Ph

2,4,6-triF-Ph

4-CF

3

-Ph

2-CN-Ph

CH

2

(4-F-Ph)

—NHPh

—N(CH

3

)Ph

CH

2

CH

2

CH

2

Ph

Compounds of Formula I wherein: Q = O, R

1

= n-Pr, R

3

= 6-I, R

4

= 8-I, and

CH

2

CH

2

CH

2

F

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

c-hexyl

allyl

2-butenyl

3-butenyl

5-decenyl

propargyl

2-butynyl

3-butynyl

CF

3

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

CH

2

OCH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

CH

2

CH

2

CH

2

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

Ph

4-Me-Ph

CH

2

CH

2

CH

2

N(CH

3

)

2

2-F-Ph

4-MeO-Ph

CH

2

Ph

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

Ph

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—N═CHPh

CH

2

CH

2

(4-F-Ph)

—N═CHCH

2

CH

2

CH

3

—N═C(CH

3

)

2

NHCH

2

CH

2

CH

3

N(CH

3

)

2

2,4-diCl-Ph

2,4,6-triF-Ph

4-CF

3

-Ph

2-CN-Ph

CH

2

(4-F-Ph)

—NHPh

—N(CH

3

)Ph

CH

2

CH

2

CH

2

Ph

TABLE 3

Compounds of Formula I wherein Q = O and R

1

= R

2

= n-Pr, and

R

3

R

4

R

3

R

4

R

3

R

4

6-Cl

H

6-Me

H

6-Me

3

Si

8-Br

6-Br

8-Me

6-Et

8-Br

6-Me

2

N

H

6-I

8-Br

6-MeO

H

6-EtNH

H

6-Cl

8-Cl

6-MeS

8-

6-Br

8-Me

MeO

6-Br

8-Cl

6-SCH

2

CH═CH

2

H

6-Br

8-Et

6-I

8-I

6-S(O)

2

Me

H

6-i-Pr

H

6-C≡CH

H

6-Br

8-

6-Br

8-

CF

3

OCF

3

6-C≡CH

8-Br

6-CH

2

C≡CH

H

6-CF

3

O

H

6-c-propyl

H

6-Br

7-Br

6-CH≡CH

2

H

6-CF

3

H

6-OCH

2

CH═CH

2

H

6-Br

7-Me

6-CH

2

Br

H

6-Br

Me

6-Br

5-Br

6-CH═CHBr

H

6-(c-propyl)CH

2

H

8-Br

H

6-CH

3

OCH

2

H

6-I

8-Me

6-Me

8-Br

TABLE 6

R

6

R

6

R

6

R

6

Compounds of Formula II wherein: Q = O, n = 0, R

5

= n-Pr, R

3

= 6-Br, R

4

= H, and

CH

2

C(CH

3

)═CH

2

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

CH

2

CH(CH

3

)CH

2

CH

3

allyl

2-butenyl

3-butenyl

5-heptenyl

propargyl

2-butynyl

3-butynyl

CF

3

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

CH

2

CH

2

O(CH

2

)

2

CH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

(CH

2

)

4

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

Ph

4-Me-Ph

CH

2

CH

2

CH

2

N(CH

3

)

2

2-F-Ph

4-MeO-Ph

(CH

2

)

4

Ph

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

CH

2

Ph

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—N═CHPh

CH

2

CH

2

(4-F-Ph)

4-Cl-Ph

2-Me-Ph

NHCH

2

CH

2

CH

3

N(CH

3

)

2

2,4-diCl-Ph

2,4,6-triF-Ph

4-CF

3

-Ph

2-CN-Ph

—NHPh

—N(CH

3

)Ph

CH

2

CH

2

CH

2

(4-F-Ph)

Compounds of Formula II wherein: Q = O, n = 0, R

5

= n-Pr, R

3

= 6-I, R

4

= H, and

CH

2

C(CH

3

)═CH

2

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

CH

2

CH(CH

3

)CH

2

CH

3

allyl

2-butenyl

3-butenyl

5-heptenyl

propargyl

2-butynyl

3-butynyl

CF

3

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

CH

2

CH

2

O(CH

2

)

2

CH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

(CH

2

)

4

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

Ph

4-Me-Ph

CH

2

CH

2

CH

2

N(CH

3

)

2

2-F-Ph

4-MeO-Ph

CH

2

Ph

CH

2

CH

2

OCH

2

CH═CH

2

CH

2

CH

2

CH

2

Ph

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—N═CHPh

CH

2

CH

2

CH

2

(4-F-Ph)

4-Cl-Ph

2-Me-Ph

NHCH

2

CH

2

CH

3

N(CH

3

)

2

2,4-diCl-Ph

2,4,6-triF-Ph

4-CF

3

-Ph

2-CN-Ph

—NHPh

—N(CH

3

)Ph

TABLE 7

Compounds of Formula II wherein Q = O, n = 0, R

5

= R

6

= n-Pr, and

R

3

R

4

R

3

R

4

R

3

R

4

6-Cl

H

6-Me

H

6-Me

3

Si

8-Br

6-Br

8-Me

6-Et

8-Br

6-Me

2

N

H

6-I

8-Br

6-MeO

H

6-EtNH

H

6-Cl

8-Cl

6-MeS

8-MeO

6-Br

8-Me

6-Br

8-Cl

6-SCH

2

CH═CH

2

H

6-Br

8-Et

6-I

8-I

6-S(O)

2

Me

H

6-i-Pr

H

6-C≡CH

H

6-Br

8-CF

3

6-Br

8-

OCF

3

6-C≡CH

8-Br

6-CH

2

C≡CH

H

6-CF

3

O

H

6-c-propyl

H

6-Br

7-Br

6-CH≡CH

2

H

6-CF

3

H

6-

H

6-Br

7-Me

OCH

2

CH═CH

2

6-CH

2

Br

H

6-Br

Me

6-Br

5-Br

6-CH═CHBr

H

6-(c-

H

8-Br

H

propyl)CH

2

6-MeOCH

2

H

6-I

8-Me

6-Me

8-Br

TABLE 10

R

9

R

9

R

9

R

9

Compounds of Formula III wherein: Q = O, R

7

= n-Pr, R

8

= H, R

3

= 6-Br, R

4

= H, and

Et

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

CH

2

CH(CH

3

)CH

2

CH

3

allyl

2-butenyl

3-butenyl

5-heptenyl

propargyl

2-butynyl

3-butynyl

CH

2

CH

2

CH

2

Cl

CH

2

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

CH

2

CH

2

O(CH

2

)

2

CH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

(CH

2

)

3

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

—N═CHPh

—NHPh

CH

2

CH

2

CH

2

N(CH

3

)

2

c-propyl

c-hexyl

—NC(═O)NHPh

CH

2

CH

2

OCH

2

CH═CH

2

—N(═S)NHPh

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—NHCH

2

CH

2

CH

3

N(CH

3

)

3

+

I

−

—N═CHCH

2

CH

2

CH

3

—N═C(CH

3

)

2

NHCH

2

CH

2

CH

3

N(CH

3

)

2

—OCH

2

CH

2

CH

3

(CH

2

)

3

(2,4,6-triF-Ph)

CH

2

(4-CF

3

-Ph)

—OCH

2

CH(CH

3

)

2

Compounds of Formula III wherein: Q = O, R

7

= n-Pr, R

8

= H, R

3

= 6-I, R

4

= H, and

Et

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

CH

2

CH(CH

3

)CH

2

CH

3

allyl

2-butenyl

3-butenyl

5-heptenyl

propargyl

2-butynyl

3-butynyl

CH

2

CH

2

CH

2

Cl

CH

2

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

(CH

2

)

2

OCH

2

CH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

(CH

2

)

3

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

—N═CHPh

—NC(═O)NHPh

CH

2

CH

2

CH

2

N(CH

3

)

2

c-propyl

c-hexyl

CH

2

CH

2

NO

2

CH

2

CH

2

OCH

2

CH═CH

2

—N(═S)NHPh

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—NHCH

2

CH

2

CH

3

N(CH

3

)

3

+

I

−

—N═CHCH

2

CH

2

CH

3

—N═C(CH

3

)

2

NHCH

2

CH

2

CH

3

N(CH

3

)

2

—OCH

2

CH

2

CH

3

(CH

2

)

3

(2,4,6-triF-Ph)

CH

2

(4-CF

3

-Ph)

—OCH

2

CH(CH

3

)

2

Compounds of Formula III wherein: Q = O, R

7

= n-Pr, R

8

= H, R

3

= 6-I, R

4

= H, and

Et

t-Bu

i-Pr

n-Bu

i-Bu

s-Bu

n-pentyl

n-hexyl

n-decyl

CH

2

CH(CH

3

)CH

2

CH

3

allyl

2-butenyl

3-butenyl

5-heptenyl

propargyl

2-butynyl

3-butynyl

CH

2

CH

2

CH

2

Cl

CH

2

CH

2

CF

3

CH

2

CH═CHCl

CH

2

C≡CBr

(CH

2

)

2

OCH

2

CH

3

CH

2

OCH

2

CH

3

CH

2

CH

2

OCH

3

CH

2

SCH

3

CH

2

CH

2

SCH

3

CH

2

CH

2

CH

2

S(O)

2

CH

3

(c-pentyl)CH

2

2-Cl-Et

CH

2

CH

2

OCH

2

C≡CH

CH

2

CH

2

SCH

2

CH═CH

2

(c-propyl)OCH

2

(c-hexyl)SCH

2

CH

2

CH

2

OCF

3

CH

2

CH

2

SCH

2

C≡CH

(CH

2

)

3

CN

CH

2

CH

2

Si(CH

3

)

3

CH

2

CH

2

CO

2

Et

CH

2

CH

2

OCH

2

CCl═CH

2

CH

2

OCH

2

CH

2

Cl

—N═CHPh

—NHPh

CH

2

CH

2

CH

2

N(CH

3

)

2

c-propyl

c-hexyl

—NC(═O)NHPh

CH

2

CH

2

OCH

2

CH═CH

2

—N(═S)NHPh

CH

2

CH

2

CH

2

NHCH

3

CH

2

CH

2

NO

2

—NHCH

2

CH

2

CH

3

N(CH

3

)

3

+

I

−

—N═CHCH

2

CH

2

CH

3

—N═C(CH

3

)

2

NHCH

2

CH

2

CH

3

N(CH

3

)

2

—OCH

2

CH

2

CH

3

(CH

2

)

3

(2,4,6-triF-Ph)

CH

2

(4-CF

3

-Ph)

—OCH

2

CH(CH

3

)

2

Ph

4-F-Ph

2-Me-Ph

2,4-diCl-Ph

TABLE 11

Compounds of Formula III wherein Q = O, R

8

= H, R

7

= R

9

= n-Pr, and

R

3

R

4

R

3

R

4

R

3

R

4

6-Cl

H

6-Me

H

6-Me

3

Si

8-Br

6-Br

8-Me

6-Et

8-Br

6-Me

2

N

H

6-I

8-Br

6-MeO

H

6-EtNH

H

6-Cl

8-Cl

6-MeS

8-MeO

6-Br

8-Me

6-Br

8-Cl

6-SCH

2

CH═CH

2

H

6-Br

8-Et

6-I

8-I

6-S(O)

2

Me

H

6-i-Pr

H

6-C≡CH

H

6-Br

8-CF

3

6-Br

8-

OCF

3

6-C≡CH

8-Br

6-CH

2

C≡CH

H

6-CF

3

O

H

6-c-propyl

H

6-Br

7-Br

6-CH═CH

2

H

6-CF

3

H

6-

H

6-Br

7-Me

OCH

2

CH═CH

2

6-CH

2

Br

H

6-Br

5-Me

6-Br

5-Br

6-CH═CHBr

H

6-(c-propyl)CH

2

H

8-Br

H

6-MeOCH

2

H

6-I

8-Me

6-Me

8-Br

Formulation/Utility

Compounds of this invention will generally be used in formulation with an agriculturally suitable composition. The fungicidal compositions of the present invention comprise an effective amount of at least one compound of Formula I, II, or III as defined above and at least one of (a) a surfactant, (b) an organic solvent, and (c) at least one solid or liquid diluent. Useful formulations can be prepared in conventional ways. They include dusts, granules, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation. The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up 100 weight percent.

Weight Percent

Active

Ingredient

Diluent

Surfactant

Wettable Powders

5-90

0-74

1-10

Oil Suspensions, Emulsions,

5-50

40-95

0-15

Solutions, (including

Emulsifiable

Concentrates)

Dusts

1-25

70-99

0-5

Granules, Baits and Pellets

0.01-99

5-99.99

High Strength Compositions

90-99

0-10

0-2

Typical solid diluents are described in Watkins, et al.,

Handbook of Insecticide Dust Diluents and Carriers,

2nd Ed., Dorland Books, Caldwell, N.J. Typical liquid diluents and solvents are described in Marsden,

Solvents Guide,

2nd Ed., Interscience, New York, (1950).

McCurcheon's Detergents and Emulsifiers Annual,

Allured Publ. Corp., Ridgewood, N.J., as well as Sisely and Wood,

Encyclopedia of Surface Active Agents,

Chemical Publ. Co., Inc., New York, (1964), list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, and the like.

Methods for formulating such compositions are well known. Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill. Water-dispersible granules can be produced by agglomerating a fine powder composition; see for example, Cross et al.,

Pesticide Formulations,

Washington, D.C., (1988), pp 251-259. Suspensions are prepared by wet-milling; see, for example, U.S. Pat. No. 3,060,084. Granules and pellets can be made by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, “Agglomeration”,

Chemical Engineering,

Dec. 4, 1967, pp 147-148,

Perry's Chemical Engineer's Handbook,

4th Ed., McGraw-Hill, New York, (1963), pp 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. Pat. No. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in DE 3,246,493.

For further information regarding the art of formulation, see U.S. Pat. No. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10 through 41; U.S. Pat. No. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12,15,39,41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. Pat. No. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman,

Weed Control as a Science,

John Wiley and Sons, Inc., New York, (1961), pp 81-96; and Hance et al.,

Weed Control Handbook,

8th Ed., Blackwell Scientific Publications, Oxford, (1989).

In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound 1 refers to the compound described in Index Table A hereinafter.

Example A

Wettable Powder

Compound 1

65.0%

dodecylphenol polyethylene glycol ether

2.0%

sodium ligninsulfonate

4.0%

sodium silicoaluminate

6.0%

montmorillonite (calcined)

23.0%.

Example B

Granule

Compound 37

10.0%

attapulgite granules (low volative

90.0%.

matter, 0.71/0.30 mm; U.S.S. No.

25-50 sieves)

Example C

Extruded Pellet

Compound 25

25.0%

anhydrous sodium sulfate

10.0%

crude calcium ligninsulfonate

5.0%

sodium alkylnaphthalenesulfonate

1.0%

calcium/magnesium bentonite

59.0%.

Example D

Emulsifiable Concentrate

Compound 37

20.0%

blend of oil soluble sulfonates

10.0%

and polyoxyethylene ethers

isophorone

70.0%.

The compounds of this invention are useful as plant disease control agents, especially for the control of cereal powdery mildews (e.g.,

Erysiphe graminis f. sp. tritici,

the causal agent of wheat powdery mildew). The present invention therefore further comprises a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, or to the plant seed or seedling to be protected, an effective amount of a compound of Formula I, II, or III or a fungicidal composition containing said compound. The compounds and compositions of this invention provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete, Oomycete and Deuteromycete classes. They are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, vegetable, field, cereal, and fruit crops. These pathogens include

Plasmopara viticola, Phytophthora infestans, Peronospora tabacina, Pseudoperonospora cubensis, Pythium aphanidermatum, Alternaria brassicae, Septoria nodorum, Cercosporidium personatum, Cercospora arachidicola, Pseudocercosporella herpotrichoides, Cercospora bericola, Bortrytis cinerea, Monilinia fructicola, Pyricularia oryzae, Podosphaera leucotricha, Venturia inaequalis, Erysiphe graminis, Uncinula necatur, Puccinia recondita, Puccinia graminis, Hemileia vastatrix, Puccinia striiformis, Puccinia arachidis, Rhizoctonia solani, Sphaerotheca fuliginea, Fusarium oxysporum, Verricillium dahliae, Pythium aphanidermatum, Phytophthora megasperma

and other generea and species closely related to these pathogens.

Compounds of this invention can also be mixed with one or more other insecticides, fungicides, nematocides, bactericides, acaricides, semiochemicals, repellants, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of agricultural protection. Examples of other agricultural protectants with which compounds of this invention can be formulated are: insecticides such as acephate, avermectin B, azinphosmethyl, bifenthrin, biphenate, buprofezin, carbofuran, chlordimeform, chlorpyrifos, cyfluthrin, deltamethrin, diazinon, diflubenzuron, dimethoate, esfenvalerate, fenpropathrin, fenvalerate, fipronil, flucythrinate, flufenprox, fluvalinate, fonophos, isofenphos, malathion, metaldehyde, metha-midophos, methidathion, methomyl, methoprene, methoxychlor, monocrotophos, oxamyl, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, rotenone, sulprofos, terbufos, tetrachlorvinphos, thiodicarb, tralomethri, triclorfon and triflumuron; fungicides such as benomyl, blasticidin S, bromuconazole, captafol, captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts, cymoxanil, cyproconazole, cyrodinil, dichloran, diclobutrazol, diclomezine, difenoconazole, diniconazole, dodine, edifenphos, epoxyconazole fenaritnol, fenbuconazole, fenpropidine, fenpropinorph, fluquinconazole, flusilazol, flutolanil, flutriafol, folpet, furalaxyl, hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, mancozeb, maneb, mepronil, metalaxyl, metconazole, myclobutanil, neo-asozin, oxadixyl, penconazole, pencycuron, phosethyl-Al, probenazole, prochloraz, propiconazole, pyrifenox, pyrimethanil, pyroquilon, sulfur, tebuconazole, tetraconazole, thiabendazole, thiophanate-methyl, thiuram, triadimefon, triadinenol, tricylazole, triticonazole, uniconzole, validamycin and vinclozolin; nematocides such as aldoxycarb, fenamiphos and fosthietan; bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as amitraz, binapacryl, chlorobenzilate, cyhexatin, dicofol, dienochlor, fenbutatin oxide, hexythiazox, oxythioquinox, propargite and tebufenpyrad; and biological agents such as

Bacillus thuringiensis

and baculovirus.

In certain instances, combinations with other fungicides having a similiar spectrum of control but a different mode of action will be particularly advantageous for resistance management. Preferred combinations comprise a compound of Formula I, II, or III, and a fungicide selected from the group flusilazole, cyproconazole, tetraconazole, fenpropimorph, fenpropidine, cymoxanil, benomyl, carbendazim, mancozeb, and maneb.

Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre- or post-infection, to the portion of the plant to be protected such as the roots, stems, foliage, fruit, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compounds can also be applied to the seed to protect the seed and seedling.

Rates of application for these compounds can be influenced by many factors of the environment and should be determined under actual use conditions. Foliage can normally be protected when treated at a rate of from less than 1 g/ha to 5,000 g/ha of active ingredient. Seed and seedlings can normally be protected when seed is treated at a rate of from 0.1 to 10 g per kilogram of seed.

The following TESTS demonstrate the control efficacy of compounds of this invention on specific pathogens. The pathogen control protection afforded by the compounds is not limited, however, to these species. See Index Tables A, B, and C for compound descriptions.

Test-compounds were first dissolved in acetone in an amount equal to 3% of the final volume and then suspended at a concerion of 200 ppm in purified water containing 250 ppm of the surfactant Trem® 014(polyhydric alcohol esters). The resulting test suspensions were then used in the following tests.

TEST A

The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore dust of

Erysiphe graminis

f. sp. tritici, (the causal agent of wheat powdery mildew) and incubated in a growth chamber at 20° C. for 7 days, after which disease ratings were made.

TEST B

The test suspension was sprayed to the point of run-off on wheat seedlings. The following day the seedlings were inoculated with a spore suspension of

Puccinia recondita

(the causal agent of wheat leaf rust) and incubated in a saturated atmosphere at 20° C. for 24 h, and then moved to a growth chamber at 20° C. for 6 days, after which disease ratings were made.

TEST C

The test suspension was sprayed to the point of run-off on tomato seedlings. The following day the seedlings were inoculated with a spore suspension of

Phytophthora infestans

(the causal agent of potato and tomato late blight) and incubated in a saturated atmosphere at 20° C. for 24 h, and then moved to a growth chamber at 20° C. for 5 days, after which disease ratings were made.

TEST D

The test suspension was sprayed to the point of run-off on grape seedlings. The following day the seedlings were inoculated with a spore suspension of

Plasmopara viticola

(the causal agent of grape downy mildew) and incubated in a saturated atmosphere at 20° C. for 24 h. moved to a growth chamber at 20° C. for 6 days, and then incubated in a saturated atmosphere at 20° C. for 24 h. after which disease ratings were made.

TEST E

The test suspension was sprayed to the point of run-off on cucumber seedlings. The following day the seedlings were inoculated with a spore suspension of

Botrytis cinerea

(the causal agent of gray mold on many crops) and incubated in a saturated atmosphere at 20° C. for 48 h, and moved to a growth chamber at 20° C. for 5 days, after which disease ratings were made.

In the Tables below, a=

1

H NMR data for oils are listed in Index Table D

INDEX TABLE A

Ia

Compounds of Formula Ia:

Cmpd No.

R

1

R

2

R

3

R

4

m.p.

a

(° C.)

1

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Br

H

57-59

2

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

7-Cl

H

57-60

3

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

5-O

H

69-75

4

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

8-Me

H

47-49

5

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

5-Me

H

Oil

6

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Me

H

47-50

7

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-OMe

7-OMe

112-114

8

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

7-F

H

oil

9

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

7-NO2

H

64-66

10

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-OMe

H

4-2

11

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Me

8-Me

81-84

12

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-C≡CH

H

105-107

13

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-F

H

60-62

14

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Cl

H

64-66

15

CH

2

CH

2

CH

3

CH

2

CH═CH

2

6-Cl

H

78-80

16

CH

2

CH

2

CH

3

CH

2

CH═CH

2

6-Br

H

73-75

17

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Cl

8-Cl

78-80

18

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Br

8-Br

89-94

22

CH

2

CH

2

CH

3

(CH

2

)

3

CH

3

6-Br

H

58-59

23

CH

2

CH

2

CH

3

i-Pr

6-Br

H

45-46

25

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-I

H

48-49

26

CH

2

CH

2

CH

3

(CH

2

)

4

CH

3

6-Br

H

56-57

27

CH

2

CH

2

CH

3

(CH

2

)

5

CH

3

6-Br

H

oil

28

CH

2

CH

2

CH

3

i-Pr

6-Cl

H

48-49

29

(CH

2

)

3

CH

3

CH

2

CH

2

CH

3

6-Br

H

56-58

30

CH

2

CH

2

CH

3

CH

2

CH

2

CH═CH

2

6-Cl

H

oil

31

CH

2

CH

2

CH

3

CH

2

CH

2

C(CH

3

)

3

6-Br

H

70-72

32

CH

2

CH

2

CH

3

(CH

2

)

3

CH

2

SCH

3

6-Br

H

86-91

33

CH

2

CH

2

CH

3

CH

2

CH

2

CH═CH

2

6-Br

H

oil

34

CH

2

CH

2

CH

3

(CH

2

)

4

CH

3

6-Cl

H

oil

35

CH

2

CH

2

CH

3

(CH

2

)

4

CH

3

6-I

H

47-49

36

CH

2

CH

2

CH

3

CH

2

CH

2

CH═CH

2

6-I

H

43-46

37

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-I

8-I

135-138

38

(CH

2

)

3

CH

3

(CH

2

)

3

CH

3

6-Br

H

oil

39

CH

2

CH

2

CH

3

(CH

2

)

2

CH

2

Ph

6-Br

H

72-74

40

CH

2

CH

2

CH

3

CH

2

CH

2

OCH

3

6-Br

H

55-57

41

CH

2

CH

2

CH

3

CH

2

CH

2

N(CH

3

)2

6-Br

H

39-42

42

CH

2

CH

2

CH

3

CH

2

CH

2

N(CH

3

)2HCl

6-Br

H

215-230

43

(CH

2

)

3

N(CH

3

)2

CH

2

CH

2

CH

3

6-Br

H

oil

44

(CH

2

)

3

OCH

3

CH

2

CH

2

CH

3

6-Br

H

61-64

45

CH

2

CH(CH

3

)2

CH

2

CH

2

CH

3

6-Br

H

50-55

46

(c-propyl)CH

2

CH

2

CH

2

CH

3

6-Br

H

99-101

47

CH(CH

3

)Et

CH

2

CH

2

CH

3

6-Br

H

oil

48

(CH

2

)

4

CH

3

(CH

2

)

4

CH

3

6-Br

H

oil

49

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-NO2

H

68-75

50

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-C≡C—SiMe

3

H

76-78

51

CH

2

CH

2

CH

3

CH

2

CH

2

CH

2

CH

3

6-I

H

54-57

52

(CH

2

)

3

CH

3

(CH

2

)

3

CH

3

6-I

H

50-51

53

(CH

2

)

3

CH

3

CH

2

CH

2

CH

3

6-I

H

50-52

54

(CH

2

)

3

SCH

3

CH

2

CH

2

CH

3

6-Br

H

69-71

55

CH

2

CH

2

CH

3

CH

2

CH

2

N

+

(CH

3

)

3

I

−

6-Br

H

223-225

56

(CH

2

)

3

N

+

(CH

3

)

3

I

−

CH

2

CH

2

CH

3

6-Br

H

200-204

57

(CH

2

)

3

N(CH

3

)2HCl

CH

2

CH

2

CH

3

6-Br

H

145-150

58

CH

2

CHBrCH

2

Br

CH

2

CH

2

CH

3

6-Br

H

118-121

59

CH

2

CH

2

(N-1,4-morpholinyl)

CH

2

CH

2

CH

3

6-Br

H

103-105

INDEX TABLE B

IIa

Compounds of Formula IIa:

Cmpd No.

R

5

R

6

R

3

R

4

m.p.(° C.)

60

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-I

H

90-92

61

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Br

H

65-67

INDEX TABLE B

IIa

Compounds of Formula IIa:

Cmpd No.

R

5

R

6

R

3

R

4

m.p.(° C.)

60

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-I

H

90-92

61

CH

2

CH

2

CH

3

CH

2

CH

2

CH

3

6-Br

H

65-67

Index Table D

Cmpd

No.

1

H NMR Data

b

5

7.46 (dd,1H), 7.29 (d,1H), 7.04 (d,1H), 4.42 (t,2H),

4.02 (m,2H), 2.84 (s.3H), 1.85 (m,2H), 1.71 (m,2H), 1.06

(t,3H), 0.98 (t,3H).

8

8.17 (dd,1H), 7.09 (dd,1H), 7.00 (dt,1H), 4.43 (t,2H), 4.05

(m,2H), 1.85 (m,2H), 1.73 (m,2H), 1.07 (t,3H), 0.97 (t,3H).

27

0.93-0.99 (2-t,6H), 1.37 (m,4H), 1.48 (m,2H), 1.75 (m,2H),

1.80 (m,2H), 4.05 (t,2H), 4.46 (t,2H), 7.34 (d,1H), 7.70 (d,1H),

8.30 (s,1H).

30

0.94-0.98 (t,3H), 1.70 (m,2H), 2.59 (m,2H), 4.02 (t,2H), 4.53

(t,2H), 5.19 (dd,2H), 5.90 (m,1H), 7.40 (d,1H), 7.59

(d,1H), 8.12 (s,1H).

33

0.93-0.98 (t,3H), 1.70 (m,2H), 2.60 (q,2H), 4.03 (t,2H),

4.51-4.55 (t,2H), 5.20 (dd,2H), 8.29, 8.30 (m,1H).

34

0.95-0.99 (m,6H), 1.41 (m,4H), 1.70 (m,2H), 1.81 (m,2H), 4.05

(t,2H), 4.44-4.48 (t,2H), 7.40 (d,1H), 7.58 (d,1H), 8.13 (s,1H).

38

0.94-1.03 (2-t,6H), 1.40 (m,2H), 1.48 (m,2H), 1.65 (m,2H),

1.80 (m,2H), 4.10 (t,2H), 4.47 (t,2H), 7.34 (d,1H), 7.70

(d,1H), 8.29 (s,1H).

43

2.22 (s,6H), 7.33 (d,1H), 7.71 (d,1H), 8.30 (s,1H).

47

1.45 (d,3H), 7.30 (d,1H), 7.68 (d,1H), 8.29 (s,1H).

48

7.31 (d,1H), 7.69 (d,1H),8.30 (s,1H).

63

0.88-0.92 (m,9H), 1.59 (m,4H), 1.75 (m,2H), 3.09-3.13

(t,4H), 4.08 (t,2H), 7.38 (d,1H), 7.70 (d,1H), 8.30 (s,1H).

70

0.99 (m,6H), 1.44 (m,4H), 1.66 (m,2H), 3.53 (q,2H), 4.00

(t.2H), 4.49 (s,1H), 7.25 (d,1H), 7.61 (d 1H), 8.10 (s,1H).

72

8.40 (s,1H), 7.89 (d,1H), 7.10 (d,1H), 4.50 (s,1H), 4.0 (t,2H),

3.53 (q,2H), 1.68 (m,4H), 1.45 (m,4H), 0.96-1.01 (m,6H).

73

8.40 (s,1H), 7.79 (d,1H), 7.10 (d,1H), 4.52 (s,1H), 4.0 (t,2H),

3.49 (q.2H), 1.70 (m.4H), 1.43 (m,2H), 0.96-1.02 (m,6H).

b

Unless indicated otherwise.

1

H NMR spectra were obtained in CDCl

3

on a 400 MHz spectrometer. Data are reported in ppm downfield from tetramethylsilane; s = singlet, d = doublet, t = triplet, m = multiplet, dd = doublet of doublets, dt = doublet of triplets.

Results for Tests A-E are given in Table 13. In the table, a rating of 100 indicates 100% disease control and a rating of 0 indicates no disease control (relative to the controls). “−” =not tested.

TABLE 13

Test

Test

Test

Test

Test

Cmpd No.

A

1

B

C

D

E

1

100

4

24

58

0

2

75

7

0

18

0

3

72

59

0

92

0

4

41

3

0

26

0

5

54

0

23

50

0

6

45

0

0

0

81

7

7

57

23

50

0

8

14

3

0

26

0

9

96

0

0

39

0

10

40

0

0

17

67

12

100

0

0

91

83

13

95

2

0

0

0

0

14

100

0

0

41

45

15

99

3

0

0

41

4

16

100

3

0

0

41

0

17

99

3

0

33

0

0

18

100

3

20

20

0

32

22

100

0

0

41

0

23

97

46

0

0

0

25

100

3

46

0

8

0

26

—

4

1

0

6

0

27

100

7

0

18

0

29

97

46

0

0

0

30

100

3

3

0

26

0

31

38

3

0

26

0

32

100

3

3

0

26

0

33

100

3

0

81

0

34

100

3

3

0

68

0

35

100

3

0

0

0

0

36

100

3

3

0

50

0

37

100

3

93

26

13

0

38

100

3

54

66

99

0

39

99

3

0

0

16

0

40

100

3

54

100

16

0

41

100

0

23

41

0

42

—

0

23

0

0

43

100

3

62

45

62

0

44

100

3

62

0

0

0

45

100

3

0

0

0

67

46

100

3

0

0

17

0

47

50

1

0

0

0

0

48

92

3

61

0

0

0

49

36

16

0

56

0

50

99

3

0

0

56

0

51

100

3

4

0

56

63

52

100

3

57

0

10

36

53

100

3

4

0

83

36

54

95

43

0

10

0

55

59

3

81

0

74

0

56

57

3

92

0

17

0

57

91

12

23

99

37

58

98

—

—

—

—

59

100

56

0

8

0

60

—

0

0

7

0

61

100

3

15

0

33

65

62

99

83

19

98

28

63

97

0

42

100

28

64

100

3

76

43

0

0

65

100

3

23

2

0

96

44

66

99

0

0

0

0

67

89

3

7

0

18

0

68

100

3

0

26

13

0

69

94

79

80

89

0

70

97

63

0

100

0

71

100

3

57

0

56

63

72

100

3

4

0

91

63

73

100

57

0

72

63

76

99

3

16

21

9

0

77

99

52

44

100

68

79

97

2

6

0

39

0

80

100

3

57

0

56

0

1

Test was run at 10 ppm unless otherwise indicated.

2

Test was run at 40 ppm.

3

Test was run at 2 ppm.

Number	Name	Date
3558610	Breuer et al.	Jan 1971
3560619	Harrison et al.	Feb 1971
3692527	König et al.	Sep 1972
3714354	Stam	Jan 1973
3755582	Bullock et al.	Aug 1973
3784693	Habeck et al.	Jan 1974
3867384	Bullock et al.	Feb 1975
4276295	Ishikawa et al.	Jun 1981
4521420	Maurer et al.	Jun 1985
4833144	Takahashi et al.	May 1989
4861780	Takahashi et al.	Aug 1989
5008266	Takahashi et al.	Apr 1991
5276038	Takasugi et al.	Jan 1994
5304530	Cliff et al.	Apr 1994
5354755	Takasugi et al.	Oct 1994
5747497	Bereznak	May 1998

Number	Date	Country
2 218 301	Oct 1973	DE
210 452	Jun 1984	DE
253 622	Jan 1988	DE
0 276 825	Aug 1988	EP
1153481	May 1969	GB

	Number	Date	Country
Parent	08/545827		US
Child	09/007336		US

Fungicidal fused bicyclic pyrimidinones

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Parent Case Info

US Referenced Citations (16)

Foreign Referenced Citations (5)

Non-Patent Literature Citations (20)

Continuations (1)

Entry
Grout et al, J. Chem. Soc., 3551-3557, Sep. 1960.*
Hedayatullah et al, J. Heterocyclic Chem., 15(6), 1033-1037, Sep. 1978.*
Suesse, M. et al, Chemical Abstracts, 115(7), Abstract No. 71634p (1991).*
Bhargava, P. et al, Chemical Abstracts, 89(19), p. 573, Abstract No. 163530z (1978).*
Bhargava, P. et al, Chemical Abstracts, 89(13), p. 908, Abstract No. 109345e (1978).*
Bhargava, P. et al, Chemical Abstracts, 85(1), p. 450, Abstract No. 5582f (1976).*
Lakhan R., et al, Chemical Abstracts, 107(5), p. 396, Abstract No. 36462u (1987).*
P.N. Bhargava et al., J. Med. Chem., 553-554, 1969, Synthesis of Some New 6-Chloro-S-substitute 2-Mercapto-3-aryl-(or -alkyl-) 4(3H)-quinazolones as Antimalarials.*
P.N.Bhargava and S.N.Singh, Synthesis of Some New 6, 8-Diiodo-S-Substituted-2-Thio-3-Aryl (or Alkyl)-4(3)-Quinazolones, The Journal of Scientific Research Banaras Hindu University, XXI (1&2), 27-32, 1969-1970.*
P.N.Bhargava and M.R.Chaurasia, Studies on 4(3H)Quinazolones:Synthesis of 6,8-Disubstituted-S-Substituted-2-Thio-3-Aryl(or Alkyl)4(3H)Quinazolones, J. Indian Chem. Soc., LIII, 46-49, Jan. 1976.*
Ram Lakhan and Babban J. Rai, Synthesis and Antibacterial Activity of 2-[[w-(Dialkylamino)alkyl]thio]-3-aryl(or alkyl)-6, 8-disubstituted-4(3H)-quinazolinones, J.Chem.Eng. Data, 32, No. 3, 384-386, 1987.*
P.N.Bhargava and Radhey Shyam, Synthesis and Spectral Studies on Some Typical 4(3H)Quinazolones as Possible Antimalarials, Egypt.J.Chem., 18, No. 3 393-401, 1975.*
Bhargava et al, Chemical Abstracts, vol. 89, entry 109345 (1978).*
Bhargava et al, Chemical Abstracts, vol. 85, entry 5582 (1976).*
Bhargava et al, Chemical Abstracts, vol. 80, entry 146101 (1974).*
Bharagava et al, Chemical Abstracts, vol. 77, entry 114350 (1972).*
Choubey, Chemical Abstracts, vol. 77, entry 88423 (1972).*
Bhargava et al, Chemical Abstracts, vol. 77, entry 48388 (1972).*
Bhargava et al, Chemical Abstracts, vol. 71, entry 22098 (1969).*
Bhargava et al, Chemical Abstracts, vol. 69, entry 27375 (1968).